A clinical trial of autologous adipose-derived regenerative cell transplantation for a postoperative enterocutaneous fistula.

Tsunekazu MizushimaHidekazu TakahashiHiroshi TakeyamaAtsushi NaitoNaotsugu HaraguchiMamoru UemuraJunichi NishimuraTaishi HataIchiro TakemasaHirofumi YamamotoYuichiro DokiMasaki Mori

Published in: Surgery today (2015)

Transplantation of autologous ADRCs is safe, feasible and advantageous, as it can secure a sufficient cell count without culture or multiple passages, and will likely be effective for a postoperative enterocutaneous fistula.

Keyphrases

cell therapy
clinical trial
stem cells
patients undergoing
mesenchymal stem cells
single cell
double blind
peripheral blood
platelet rich plasma
tissue engineering